Federated Hermes’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.5M | Buy |
125,048
+58,745
| +89% | +$2.11M | 0.01% | 750 |
|
|
2025
Q1 | $2.61M | Sell |
66,303
-64,385
| -49% | -$2.54M | 0.01% | 877 |
|
|
2024
Q4 | $3.93M | Buy |
130,688
+26,887
| +26% | +$809K | 0.01% | 765 |
|
|
2024
Q3 | $2.43M | Buy |
103,801
+103,751
| +207,502% | +$2.43M | 0.01% | 886 |
|
|
2024
Q2 | $890 | Buy |
+50
| New | +$890 | ﹤0.01% | 1953 |
|
|
2023
Q4 | – | Sell |
-55
| Closed | -$460 | – | 2204 |
|
|
2023
Q3 | $460 | Sell |
55
-135
| -71% | -$1.13K | ﹤0.01% | 2044 |
|
|
2023
Q2 | $4.72K | Buy |
190
+1
| +0.5% | +$25 | ﹤0.01% | 1907 |
|
|
2023
Q1 | $2.84K | Sell |
189
-396
| -68% | -$5.96K | ﹤0.01% | 1980 |
|
|
2022
Q4 | $6.92K | Sell |
585
-581,836
| -100% | -$6.88M | ﹤0.01% | 1903 |
|
|
2022
Q3 | $3.45M | Sell |
582,421
-1,652,558
| -74% | -$9.79M | 0.01% | 755 |
|
|
2022
Q2 | $9.5M | Buy |
2,234,979
+1,452,446
| +186% | +$6.17M | 0.03% | 556 |
|
|
2022
Q1 | $7.44M | Buy |
+782,533
| New | +$7.44M | 0.02% | 681 |
|
|
2021
Q1 | – | Sell |
-6,173
| Closed | -$321K | – | 2345 |
|
|
2020
Q4 | $321K | Sell |
6,173
-35,479
| -85% | -$1.84M | ﹤0.01% | 1620 |
|
|
2020
Q3 | $1.12M | Sell |
41,652
-356,356
| -90% | -$9.54M | ﹤0.01% | 1200 |
|
|
2020
Q2 | $7.75M | Buy |
398,008
+304,957
| +328% | +$5.94M | 0.02% | 605 |
|
|
2020
Q1 | $916K | Buy |
93,051
+92,851
| +46,426% | +$914K | ﹤0.01% | 1171 |
|
|
2019
Q4 | $2K | Buy |
+200
| New | +$2K | ﹤0.01% | 2043 |
|
|
2018
Q3 | – | Sell |
-74,643
| Closed | -$982K | – | 2323 |
|
|
2018
Q2 | $982K | Buy |
74,643
+17,104
| +30% | +$225K | ﹤0.01% | 1296 |
|
|
2018
Q1 | $817K | Buy |
+57,539
| New | +$817K | ﹤0.01% | 1280 |
|